Qualification and Clinical Validation of an Immunodiagnostic Assay for Detecting 11 Additional <i>Streptococcus pneumoniae</i> Serotype–specific Polysaccharides in Human Urine
Warren V. Kalina(Pfizer (United States)), Michael W. Pride(Pfizer (United States)), Terri Mininni(Pfizer (United States)), Donna Giordano-Schmidt(Pfizer (United States)), Victor Costa de Souza(Pfizer (United States)), Charles Y. Tan(United States Military Academy), Huiming Cheng(Pfizer (United States)), Kangjian Wu(Pfizer (United States)), Manu Unnithan(Pfizer (United States)), Andrew McKeen(Pfizer (United States)), Kelly A. Belanger(Pfizer (United States)), Peter C. Giardina(Pfizer (United States)), Bradford D. Gessner(Pfizer (United States)), R. C. French(Pfizer (United States)), Kathrin U. Jansen(Pfizer (United States)), Yanhua Ren(Pfizer (United States)), Qin Jiang(Pfizer (United States)), Susan P. McElhiney(Pfizer (United States))
Cited by 54
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k